No Prescription |
 |
 | ||
|
Sompraz 40 Nexium |
|
| ||
No Prescription » Prescription Drugs 15 » Sompraz 40 Nexium Esomeprazole is used for: Treating gastroesophageal reflux disease (GERD) in patients with a history of irritation and swelling of the esophagus (food pipe) when medicine cannot be taken by mouth. Esomeprazole( (e-so-MEP-ra-zole) ) is used to treat conditions in which there is too much acid in the stomach. It is used to treat duodenal ulcers and gastroesophageal reflux disease (GERD). This is a condition in which the acid in the stomach washes back up into the esophagus. It also reduces the chance of gastric ulcers in patients who use a group of medicines called NSAIDs and who may be at greater risk (i.e. patients 60 years of age or older or patients who have a history of gastric ulcers). Sometimes esomeprazole is used along with antibiotics to treat ulcers associated with infection caused by the H. pylori bacteria (germ).Esomeprazole works by decreasing the amount of acid produced by the stomach. Buy Sompraz 40 Nexium and other Prescription Drugs 15 products online at Medstore. 3491
About Sompraz 40 Nexium: Product Type: Prescription Drugs 15 Sompraz - 40 ( Nexium Generic Esomeprazole ) Sompraz - 40 (Nexium Generic Esomeprazole) Nexium Generic Esomeprazole 40mg 90 (9 x 10) tabs Nexium Generic Esomeprazole Sompraz - 40
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
